Abbott Targets Teva Over Latest Simcor ANDA
Abbott Laboratories on Friday continued its bid to protect the market for cholesterol drug Simcor, filing another patent infringement suit in Delaware against generic-drug maker Teva Pharmaceutical Industries Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article